CBD Life Sciences (CBDL) Stock Price, News & Analysis

Company Overview

CBD Life Sciences, Inc. (OTCMKTS:CBDL) is a biotechnology and life sciences company specializing in the development of novel therapies and strategic advisory services centered on cannabinoids and natural bioactive compounds. Through its core team of scientists and consultants, the company offers end-to-end support for the design, optimization and implementation of preclinical and clinical development programs. Its expertise spans drug discovery, formulation development and regulatory strategy, with an emphasis on translating laboratory research into viable therapeutic candidates.

In addition to its internal research and development pipeline, CBD Life Sciences provides a range of commercial services to partner organizations and emerging biotech firms. These services include customized contract research, regulatory consulting, intellectual property evaluation and business development support. The company leverages collaborations with academic institutions, contract research organizations and manufacturing partners to advance projects across oncology, immunology and other therapeutic areas where cannabinoid-based approaches have shown potential.

Headquartered in North America, CBD Life Sciences operates on a global basis, serving clients in the United States, Europe and select markets in Asia. By combining expertise in cannabinoid pharmacology with a broad network of industry relationships, the company seeks to accelerate the development and commercialization of safe, effective products derived from natural compounds. CBD Life Sciences continues to refine its strategic focus on high-value therapeutic opportunities while expanding its advisory footprint in the rapidly evolving biopharma landscape.

Key Stats

• Today's Range: $0.0002 to $0.0003
• 50-Day Range: N/A
• 52-Week Range: $0.0001 to $0.0022
• Volume: 5.58 million shs
• Average Volume: 21.17 million shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

CBDL Stock Analysis - Frequently Asked Questions

How have CBDL shares performed this year?

CBD Life Sciences' stock was trading at $0.0005 at the beginning of the year. Since then, CBDL stock has decreased by 40.0% and is now trading at $0.0003.

How do I buy shares of CBD Life Sciences?

Shares of CBDL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of CBD Life Sciences own?

Based on aggregate information from My MarketBeat watchlists, some other companies that CBD Life Sciences investors own include 3D Systems (DDD), Baidu (BIDU), Silver Bull Resources (SVBL), Workday (WDAY), Zoom Communications (ZM), Clean Energy Fuels (CLNE) and ContextLogic (WISH).

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Drug Manufacturers - Specialty & Generic
• Sub-Industry: Pharmaceutical Products
• Current Symbol: OTCMKTS:CBDL
• CIK: 1776073
• Web: www.optiumcyber.com
• Phone: (480) 410-6780
• Fax: N/A
• Employees: 4
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A